Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00299767 · ClinicalTrials.gov registry record · Phase 1
Phase I Study of Sequential Cord Blood Transplants
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00299767: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00299767 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00299767, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of sequential cord blood transplantation (2 cord blood units) for patients who have diseases that are capable of being cured by allogeneic stem cell transplant but do not have a matched family or volunteer unrelated donor.
Interventions
- PROCEDURE sequential cord blood transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-05 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00299767
The ClinicalTrials.gov registry entry for NCT00299767 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sequential cord blood transplantation is the first listed.
NCT00299767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00299767 about?
NCT00299767 is a clinical study titled "Phase I Study of Sequential Cord Blood Transplants". The purpose of this study is to determine the safety of sequential cord blood transplantation (2 cord blood units) for patients who have diseases that are capable of being cured by allogeneic stem cell transplant but do not have a matched family or volunteer unrelated donor.
What is the current status of trial NCT00299767?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2003-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00299767?
The interventions under investigation include: sequential cord blood transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00299767?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.